Ideaya Biosciences Inc (IDYA)
Drugs • Health Care
Percentage
Change
| Mar 20 | Mar 21 | Mar 22 | Mar 23 | Feb 24 | Feb 25 | Feb 26 | |
|---|---|---|---|---|---|---|---|
Net Income to Common | -274 | -114 | |||||
Net Income | -274 | -114 | |||||
Profit | -274 | -114 | |||||
Net Income Continuing | -274 | -114 | |||||
Pretax Income | -274 | -114 | |||||
Total Non-operating Income | 52 | 46 | |||||
Operating Income | -327 | -159 | |||||
Total Revenue | 7 | 219 | |||||
Total Costs and Expenses | -334 | -378 | |||||
Operating Expenses | -334 | -378 | |||||
Research and Development Expenses | -295 | -315 | |||||
Selling, General & Administrative Expenses | -39 | -63 |